Coronavirus in Kyrgyzstan Log in  
Uzbekistan|health|November 25, 2021 / 10:41 AM
Uzbekistan to participate in clinical trial of Chinese anti-COVID-19 drug candidate

AKIPRESS.COM - Two Chinese antiviral medicine for COVID-19 mainly developed by the Shanghai Institute of Materia Medica under the Chinese Academy of Sciences (CAS) have commenced human trials overseas, Xinhua reported...

To Read the Full Story

All rights reserved

© AKIpress News Agency - 2001-2021.

Republication of any material is prohibited without a written agreement with AKIpress News Agency.

Any citation must be accompanied by a hyperlink to akipress.com.

Our address:

299/5 Chingiz Aitmatov Prosp., Bishkek, the Kyrgyz Republic

e-mail: english@akipress.org, akipressenglish@gmail.com;

Follow us: